Salt-resistant and salt-sensitive phenotypes determine the sensitivity of blood pressure to weight loss in overweight/obese patients

Journal of Clinical Hypertension

Volumn 10, Issue 5, 2008, Pages 355-361

  Hoffmann, Irene S ^a   Alfieri, Anna B ^a   Cubeddu, Luigi X ^a,b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; COMPARATIVE STUDY; DIET THERAPY; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROGNOSIS; SODIUM RESTRICTION; WEIGHT REDUCTION;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; DIET, SODIUM-RESTRICTED; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; OVERWEIGHT; PHENOTYPE; PROGNOSIS; WEIGHT LOSS;

EID: 50349098192     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.07609.x     Document Type: Article

References (39)

1. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-880.
2. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763-778.
3. Davey RC. The obesity epidemic: too much food for thought? Br J Sports Med. 2004;38:360-363.
4. Mello MM, Studdert DM, Brennan TA. Obesity-the new frontier of public health law. N Engl J Med. 2006;354:2601-2610.
5. Douketis JD, Sharma AM. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction. Semin Vasc Med. 2005;5:25-33.
6. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
7. Rocchini AP. Obesity, hypertension, salt sensitivity and insulin resistance. Nutr Metab Cardiovasc Dis. 2000;10:287-294.
8. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792-2800.
9. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799-1804.
10. Rocchini AP. Obesity hypertension. Am J Hypertens. 2002;15:50S-52S.
11. Scaglione R, Ganguzza A, Corrao S, et al. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord. 1995;19:403-409.
12. Francischetti EA, Genelhu VA. Obesity-hypertension: an ongoing pandemic. Int J Clin Pract. 2007;61:269-280.
13. Licata G, Scaglione R, Ganguzza A, et al. Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens. 1994;7:314-320.
14. Licata G, Scaglione R, Corrao S, et al. Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens. 1995;13:611-618.
15. Carmelli D, Cardon LR, Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments? Am J Hum Genet. 1994;55:566-573.
16. Cusi D, Barlassina C, Azzani T, et al. Polymorphisms of a-adducin and salt sensitivity in patients with essential hypertension. Lancet. 1997;349:1353-1357.
17. Poch E, Gonzalez D, Giner V, et al. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension. 2001;38:1204-1209.
18. Hoffmann IS , Tavares-Mordwinkin R, Castejon AM, et al. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens. 2005;19:233-240.
19. Beeks E, Kessels AG, Kroon AA, et al. Genetic predisposition to salt-sensitivity: a systematic review. J Hypertens. 2004;22:1243-1249.
20. Radin MJ, Holycross BJ, Hoepf TM, et al. Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin. Mol Cell Biochem. 2003;242:57-63.
21. Dengel DR, Brown MD, Ferrell RE , et al. Role of angiotensin converting enzyme genotype in sodium sensitivity in older hypertensives. Am J Hypertens. 2001;14(12):1178-1184.
22. Fuenmayor N, Moreira E, Cubeddu LX. Salt sensitivity is associated with insulin resistance in essential hypertension. Am J Hypertens. 1998;11(pt 4):397-402.
23. Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 1989;321:580-585.
24. Kostis JB, Wilson AC, Hooper WC, et al; TONE Cooperative Research Group. Trial of nonpharmacologic interventions in the elderly. Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss. Am Heart J. 2002;144:625-629.
25. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799-1804.
26. Hoffmann IS , Alfieri AB, Cubeddu LX. Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese salt-sensitive Hispanics. J Hum Hypertens. 2007;21(7):571-578.
27. Vitale C, Mercuro G, Cornoldi A, et al. Metformin improves endothelial function in patients with metabolic syndrome. J Intern Med. 2005;258:250-256.
28. Ratner R, Goldberg R, Haffner S, et al. Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005;28:888-894.
29. Knowler WC, Barrett-Connor E, Fowler SE , et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
30. Suzuki H, Ikenaga H, Hayashida T, et al. Sodium balance and hypertension in obese and fatty rats. Kidney Int Suppl. 1996;55:S150-S153.
31. Weinberger MH, Fineberg NS, Fineberg SE , et al. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37:429-432.
32. Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006;24(8):1627-1632.
33. Dengel DR, Brown MD, Ferrell RE , et al. Role of angiotensin converting enzyme genotype in sodium sensitivity in older hypertensives. Am J Hypertens. 2001;14:1178-1184.
34. Giner V, Poch E, Bragulat E, et al. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension. 2000;35:512-517.
35. Zhang L, Miyaki K, Araki J, et al. Interaction of angiotensin I-converting enzyme insertion-deletion polymorphism and daily salt intake influences hypertension in Japanese men. Hypertens Res. 2006;29(10):751-758.
36. Cirillo M, Lombardi C, Bilancio G, et al. Urinary albumin and cardiovascular profile in the middle-aged population. Semin Nephrol. 2005;25:367-371.
37. Cubeddu LX, Hoffmann IS , Aponte LM, et al. Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. Am J Hypertens. 2003;16:343-349.
38. Dell'Omo G, Penno G, Giorgi D, et al. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis. 2002;40:1-8.
39. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110:32-35.